Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
67,744,971
-
Shares change
-
-3,012,353
-
Total reported value, excl. options
-
$1,804,059,935
-
Value change
-
-$97,241,940
-
Put/Call ratio
-
76.97%
-
Number of buys
-
81
-
Number of sells
-
-104
-
Price
-
$26.63
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2021
248 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,744,971 shares
of 100,740,741 outstanding shares and own 67.25% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (12,543,548 shares), VANGUARD GROUP INC (7,893,858 shares), BlackRock Inc. (7,241,436 shares), HHLR ADVISORS, LTD. (3,955,787 shares), FMR LLC (3,632,508 shares), STATE STREET CORP (3,421,216 shares), FIRST TRUST ADVISORS LP (3,106,832 shares), JPMORGAN CHASE & CO (2,248,233 shares), Bank of New York Mellon Corp (2,135,418 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,503,558 shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.